What happens when you take cbd with beta-blockers?
Beta-blockers are a foundational class of cardiovascular medications used for hypertension, angina, atrial fibrillation, heart failure, post-myocardial-infarction protection, migraine prophylaxis, essential tremor, and performance anxiety. Common agents include metoprolol, propranolol, carvedilol, bisoprolol, atenolol, and nebivolol. Several of these, particularly metoprolol, propranolol, carvedilol, and nebivolol, depend heavily on the CYP2D6 hepatic enzyme for clearance. The NCBI Medical Genetics Summaries entry on metoprolol notes that most of its metabolism occurs through CYP2D6 and that reduced CYP2D6 activity, whether from genetic polymorphism or drug inhibition, substantially elevates plasma metoprolol concentrations.
Cannabidiol (CBD) is a moderate inhibitor of several CYP450 enzymes, most prominently CYP3A4, CYP2C19, CYP2C9, and CYP1A2, with weaker but documented activity at CYP2D6. The clinically established potent inhibitors of CYP2D6 are drugs like fluoxetine, paroxetine, bupropion, and quinidine, and CBD is in a lower tier, but in heavy or chronic users it can still add meaningfully to the metabolic load on the enzyme. On top of the pharmacokinetic effect, CBD itself has been observed in clinical studies to slightly lower blood pressure, particularly in stress-test conditions, so the pharmacodynamic effect runs in the same direction as the beta-blocker.
Why is this important?
Beta-blockers are dose-titrated to a heart-rate and blood-pressure target. Any unplanned increase in plasma drug level pushes the patient past that target into bradycardia, postural hypotension, fatigue, dizziness, and the risk of syncope and falls. In older adults, syncope and falls translate quickly into hip fractures, head injuries, and hospital admissions. Patients with heart failure on carvedilol or bisoprolol are especially fragile because their cardiac reserve is already limited and a slow pulse plus low pressure can precipitate decompensation.
The interaction is also relevant for performance anxiety and essential-tremor use of propranolol, where doses are smaller but users may add CBD specifically to enhance the calming effect. The combination can feel pleasantly relaxed at first but can drop pulse below 50 beats per minute and produce lightheadedness on standing.
Patients are often surprised by the interaction because beta-blockers are not on the standard 'CBD danger' list that is widely circulated, which tends to emphasize warfarin, antiepileptics, and immunosuppressants. The CYP2D6 piece is real but less talked about, and the additive blood-pressure effect rarely makes it into consumer marketing material at all.
What should you do?
If you are already on a stable beta-blocker dose and you want to start CBD, do so deliberately. Begin with a low CBD dose, for example 10 to 15 milligrams once daily, and take your pulse and blood pressure twice daily for the first 14 days, ideally at the same morning and evening times. If your resting pulse drops below 50 beats per minute, your systolic blood pressure drops more than about 15 mmHg below your usual reading, or you notice new dizziness on standing, lightheadedness, near-fainting, fatigue, or cold hands and feet, stop the CBD and contact your prescriber. Do not stop the beta-blocker abruptly on your own, especially if you take it for coronary disease or arrhythmia, as rebound tachycardia and angina can result.
If you are starting a beta-blocker and already use daily CBD, tell your prescriber. They may start at a lower beta-blocker dose and titrate up more slowly, or choose a beta-blocker less reliant on CYP2D6, such as atenolol or bisoprolol, although bisoprolol still has partial CYP3A4 metabolism.
If you take CBD only occasionally, for instance the night before a stressful event, the interaction is smaller and a one-off dose is unlikely to cause clinical problems in a healthy adult on a beta-blocker. Still, take a few extra minutes when standing up the next morning and avoid driving until you are sure you feel normal.
Always make sure your full medication list, including over-the-counter CBD products, is on file with your pharmacist and your cardiology clinic. Bring the bottle to appointments so the strength per drop or gummy is clear.
Which specific products are affected?
Beta-blockers commonly used in clinical practice include metoprolol (Lopressor, Toprol-XL), propranolol (Inderal, Inderal LA, InnoPran XL), carvedilol (Coreg, Coreg CR), bisoprolol (Zebeta, Cardicor), atenolol (Tenormin), nebivolol (Bystolic), labetalol (Trandate, Normodyne), and timolol (Blocadren, oral and as Timoptic eye drops). Sotalol (Betapace) is technically a beta-blocker with class III anti-arrhythmic properties and additionally has QT-prolongation considerations that compound with CBD-driven CYP3A4 inhibition.
On the CBD side, oral and sublingual products are the relevant ones: tinctures, oils, capsules, gummies, infused beverages, sprays, and prescription Epidiolex. Topical CBD creams and balms have very low systemic absorption and are generally not a concern for this interaction. Full-spectrum and broad-spectrum oils with measurable THC introduce additional cardiovascular effects, including transient tachycardia at low doses and orthostatic hypotension at higher doses, that further complicate beta-blocker titration.
The bottom line
CBD modestly inhibits CYP2D6 and several other liver enzymes that clear common beta-blockers such as metoprolol, propranolol, and carvedilol, and CBD itself lowers blood pressure slightly. The combination tends to push pulse and pressure further down than the beta-blocker alone, with real risk of dizziness, falls, and syncope in older or cardiovascularly fragile patients. Start CBD low, monitor pulse and pressure for two weeks, and tell your cardiology team what you are taking.